Transferrin saturation with intravenous irons: An in vitro study
Author:
- 1 September 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 66 (3) , 1139-1144
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Impairment of Transendothelial Leukocyte Migration by Iron ComplexesJournal of the American Society of Nephrology, 2003
- Oxidative Stress–Induced Iron Signaling Is Responsible for Peroxide-Dependent Oxidation of Dichlorodihydrofluorescein in Endothelial CellsCirculation Research, 2003
- Issues Related to Iron Replacement in Chronic Kidney DiseaseSeminars in Nephrology, 2002
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal DiseaseCirculation, 2002
- Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injuryAmerican Journal of Kidney Diseases, 2002
- Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin‐bound iron in dialysis patientsEuropean Journal of Clinical Investigation, 2002
- Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United StatesArchives of internal medicine (1960), 2001
- Comparative Look at Intravenous Iron Agents: Pharmacology, Efficacy, and Safety of Iron Dextran, Iron Saccharate, and Ferric GluconateSeminars in Dialysis, 1999
- The detection of four molecular forms of human transferrin during the iron binding processBiochimica et Biophysica Acta (BBA) - Protein Structure, 1976